Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.
about
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsFebrile illness diagnostics and the malaria-industrial complex: a socio-environmental perspective.Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite ProteinEnhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell ResponsesSafety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the LiverAssessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.Recombinant modified vaccinia virus Ankara-based malaria vaccines.Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.Development of replication-deficient adenovirus malaria vaccines.A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage ChallengeCurrent Status and Development of Vaccines and Other Biologics for Human Rabies Prevention.Modeling Combinations of Pre-erythrocytic Plasmodium falciparum Malaria VaccinesProfiling the Targets of Protective CD8+ T Cell Responses to Infection.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.Novel Concepts for HIV Vaccine Vector Design.Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density.CXCR3 T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against MalariaMalaria Vaccines: Recent Advances and New HorizonsDevelopment of a Molecular Adjuvant to Enhance Antigen-Specific CD8 T Cell ResponsesSafety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
P2860
Q24289279-C9D64853-8610-43D9-93E4-CB65F3692508Q26781372-0F8E4858-1E56-4E8D-93B5-3A61E860AF8EQ27928033-32C9262B-9ED4-4483-8D61-E87C504433CAQ27973488-06775914-A956-465E-959C-86FBEBCA38C5Q33577093-5305B920-45A9-484C-85AA-D3C4F90DCC34Q33855899-814DF8F1-4E4C-43D6-A8B4-DD7D94E157B7Q33868760-7E8CC0B2-0D40-473A-B4D9-841B688CE745Q36178611-39CE45F0-21BA-4DDD-890D-A394B8EBE331Q36225504-F1793F68-DDE1-4D0C-A968-DD6C0B4CE752Q36394177-7C3B21F2-89CC-46F8-9E13-699013FE252CQ36905568-79DE8DD9-3EFD-44B6-BE3F-844619E03A7DQ37161928-E6E62686-4083-42E4-A01F-8BB12B6B6043Q37654676-250CCF48-9CF3-4AAD-ADAC-852664878B70Q37669809-B7EA07C6-5974-4B7A-AE15-6AE2670A9236Q38618898-EA735664-31D3-48BB-ACB7-0D23BE608D67Q38762695-B48A6B2B-FF82-4997-B5A4-8E1FDAB1AA12Q38949194-9942B957-0221-4823-986F-A2A9ACBBD78DQ39315273-11417AA3-101D-436E-9276-5D91DF69EC45Q39414342-AEA41714-C471-456F-992F-1DD00D0D5859Q40390930-A52E3053-43B3-4808-AE42-DE892760EDFFQ41693606-1653F4DA-9977-4E69-9F26-0D6127F1C138Q44106019-33F941A6-E0E7-49CC-AA8B-F922C3DE70E9Q46484016-FE335C39-4536-486D-99D6-72E1B802C9AFQ46796163-20BCE60A-5DA5-40C0-BBB9-6E63D3857EDBQ47112156-1E7E3E67-C765-46FC-9F62-DA80FC0A9A50Q47202176-531B87AA-FA25-4FBF-B59C-0B4107E2BD4FQ47607706-7D57512C-7A08-4819-885F-C66C7CF8D601Q48018507-4D9A3DD9-4D5E-48B2-922F-61A9CE321418Q50347547-443393BA-1505-4A92-8D9F-7E4D39B7D4ABQ55336656-A111B1BF-4DB6-41A1-B4DB-C8B78DCFB66EQ56357275-39ECF6D7-112E-40EE-9B14-4C205D8951DFQ56362064-ADF450D0-2BBC-4CFB-8DF5-D868CB238822Q57292428-7998A463-2F4D-4F5B-A061-44B0AB9181C3Q57480738-EE760B3D-DF0B-4922-950A-1F716F97E871
P2860
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@ast
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@en
type
label
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@ast
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@en
prefLabel
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@ast
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@en
P2093
P2860
P50
P921
P1476
Prime-boost vaccination with c ...... um infection in Kenyan adults.
@en
P2093
Alfredo Nicosia
Alison Lawrie
Caroline Ogwang
Domtila Kimani
Egeruan B Imoukhuede
Jedidah Mwacharo
Joe Illingworth
Katie Ewer
MVVC group
Nicola K Viebig
P2860
P304
P356
10.1126/SCITRANSLMED.AAA2373
P407
P50
P577
2015-05-01T00:00:00Z